We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.12%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.13B
AUM Growth
+$460M
Cap. Flow
+$219M
Cap. Flow %
10.3%
Top 10 Hldgs %
40.03%
Holding
90
New
27
Increased
17
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$32.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$23.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$19.8M
4
DXCM icon
DexCom
DXCM
+$19.6M
5
WST icon
West Pharmaceutical
WST
+$18.9M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$41.2M
2
INBX
Inhibrx, Inc. Common Stock
INBX
+$17.9M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$14.2M
4
ROIV icon
Roivant Sciences
ROIV
+$13.6M
5
SANA icon
Sana Biotechnology
SANA
+$9.05M

Sector Composition

Rank Sector Weight
1 Healthcare 90.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSBX
76
DELISTED
Turnstone Biologics
TSBX
$2.41M 0.11%
920,976
+287,663
+45% +$823K
PMVP icon
77
PMV Pharmaceuticals
PMVP
$62.9M
$2.17M 0.1%
1,275,462
-197,551
-13% -$369K
BOLD
78
Boundless Bio
BOLD
$63.8M
$2M 0.09%
+140,513
New +$2M
INBX
79
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.68M 0.08%
47,918
-490,046
-91% -$17.9M
CLDX icon
80
Celldex Therapeutics
CLDX
$3.26B
$1.47M 0.07%
35,000
– –
SRPT icon
81
Sarepta Therapeutics
SRPT
$1.77B
$1.46M 0.07%
+11,291
New +$1.38M
QURE icon
82
uniQure
QURE
$3.15B
$1.43M 0.07%
+274,540
New +$1.58M
TNYA icon
83
Tenaya Therapeutics
TNYA
$163M
$1.16M 0.05%
+222,222
New +$1.06M
PRTA icon
84
Prothena Corp
PRTA
$449M
– –
-189,744
Closed -$6.9M
ROIV icon
85
Roivant Sciences
ROIV
$25.4B
– –
-1,215,033
Closed -$13.6M
KRTX
86
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-130,293
Closed -$41.2M
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q1 2024 Portfolio in Review

As of Q1 2024, PFM Health Sciences held 90 positions worth $2.13B, up 28% from $1.67B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences deployed $219M of net new capital in Q1 2024, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 97% a quarter earlier.

On the sell side, the largest reduction was Inhibrx, Inc. Common Stock, an estimated $17.9M trimmed.

  • PFM Health Sciences's largest Q1 2024 buy was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.
  • PFM Health Sciences added most to Intuitive Surgical in Q1 2024, an estimated $32.8M increase.
  • PFM Health Sciences's biggest Q1 2024 reduction was Inhibrx, Inc. Common Stock, cutting an estimated $17.9M.
  • PFM Health Sciences fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $41.2M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $2.13B portfolio in Q1 2024.
  • PFM Health Sciences opened 27 new positions and closed 3 in Q1 2024.
  • PFM Health Sciences's portfolio value rose 28% quarter-over-quarter to $2.13B.

Based on PFM Health Sciences's 13F filing for Q1 2024, filed 14 May 2024.